Suchergebnisse - "Herbst, Roy S"

PubPharm (555)

1

Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Cartmel, B. | Fucito, L. | Bold, K. | +7

2

Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection

enthalten in: bioRxiv.org | 2024

von McPadden, J. | Warner, F. | Young, H. | +23

3

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Parra, E. | Zhang, J. | Duose, D. | +44

4

Summary of Research : Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

5

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

6

Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Brahmer, J. | Long, G. | Hamid, O. | +25

7

Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers

enthalten in: Frontiers in oncology | 2024

von Lin, D. | Huang, R. | Ladas, I. | +12

8

Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials : A review

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Majem, M. | Basch, E. | Cella, D. | +3

9

Novel Approach to Accelerate Lung Cancer Research : Lung-MAP and the Potential of Public-Private Partnerships

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Herbst, R. | Blanke, C. | Sigal, E.

10

Osimertinib in Resected EGFR-Mutated NSCLC. Reply

enthalten in: The New England journal of medicine | 2023

von Tsuboi, M. | Herbst, R. | Wu, Y.

CommentOn: N Engl J Med. 2023 Jul 13;389(2):137-147. - PMID 37272535

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[56]